Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Determinants of vascular function in patients with chronic gout.

Brook RD, Yalavarthi S, Myles JD, Khalatbari S, Hench R, Lustig S, Marder W, Neidert A, Kaplan MJ.

J Clin Hypertens (Greenwich). 2011 Mar;13(3):178-88. doi: 10.1111/j.1751-7176.2010.00406.x. Epub 2010 Dec 22.

2.

Detrimental role of hyperuricemia on the cardio-reno-vascular system.

Stack A, Manolis AJ, Ritz E.

Curr Med Res Opin. 2015;31 Suppl 2:21-6. doi: 10.1185/03007995.2015.1087984. Review.

PMID:
26414733
3.

Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout.

Juraschek SP, Kovell LC, Miller ER, Gelber AC.

PLoS One. 2013;8(2):e56546. doi: 10.1371/journal.pone.0056546. Epub 2013 Feb 27.

4.

Hyperuricemia, gout, and cardiovascular disease--an important "muddle".

Keenan RT, Pillinger MH.

Bull NYU Hosp Jt Dis. 2009;67(3):285-90. Review.

PMID:
19852752
5.

Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.

Perez-Ruiz F, Becker MA.

Curr Med Res Opin. 2015;31 Suppl 2:9-14. doi: 10.1185/03007995.2015.1087980. Review.

PMID:
26414731
6.

Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature.

van Durme C, van Echteld IA, Falzon L, Aletaha D, van der Heijde DM, Landewé RB.

J Rheumatol Suppl. 2014 Sep;92:9-14. doi: 10.3899/jrheum.140457. Review.

PMID:
25180123
7.

Beyond gout: uric acid and cardiovascular diseases.

Agabiti-Rosei E, Grassi G.

Curr Med Res Opin. 2013 Apr;29 Suppl 3:33-9. doi: 10.1185/03007995.2013.790804. Epub 2013 Apr 24. Review.

PMID:
23611366
8.

Serum uric acid independently predicts cardiovascular events in advanced nephropathy.

Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ.

Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22.

PMID:
23007099
9.

Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

Shah A, Keenan RT.

Curr Rheumatol Rep. 2010 Apr;12(2):118-24. doi: 10.1007/s11926-010-0084-3. Review.

PMID:
20425020
10.

Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia.

Meléndez-Ramírez G, Pérez-Méndez O, López-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N.

Endocr Res. 2012;37(1):1-6. doi: 10.3109/07435800.2011.566235. Epub 2011 Oct 6.

PMID:
21977925
11.

Hyperuricaemia: more than just a cause of gout?

Katsiki N, Karagiannis A, Athyros VG, Mikhailidis DP.

J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):397-402. doi: 10.2459/JCM.0b013e3283595adc. Review.

PMID:
23032963
12.

Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.

Karbowska A, Boratynska M, Kusztal M, Klinger M.

Transplant Proc. 2009 Oct;41(8):3052-5. doi: 10.1016/j.transproceed.2009.07.080.

PMID:
19857674
13.

Serum uric acid as a risk predictor for erectile dysfunction.

Salem S, Mehrsai A, Heydari R, Pourmand G.

J Sex Med. 2014 May;11(5):1118-24. doi: 10.1111/jsm.12495. Epub 2014 Mar 13.

PMID:
24621054
14.

Gout, hyperuricaemia, sleep apnoea-hypopnoea syndrome and vascular risk.

Cantalejo Moreira M, Veiga Cabello RM, García Díaz V, Racionero Casero MA, Zapatero Gaviria A.

Rheumatology (Oxford). 2013 Sep;52(9):1619-22. doi: 10.1093/rheumatology/kes418. Epub 2013 Feb 14.

PMID:
23418048
15.

[Gout and cardiovascular risk].

Němec P.

Vnitr Lek. 2014 Oct;60(10):893-901. Review. Czech.

PMID:
25382012
16.

Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile.

Lippi G, Montagnana M, Luca Salvagno G, Targher G, Cesare Guidi G.

Clin Cardiol. 2010 Feb;33(2):E76-80. doi: 10.1002/clc.20511.

17.

Hyperuricemia, gout, and cardiovascular disease: an update.

Abeles AM.

Curr Rheumatol Rep. 2015 Mar;17(3):13. doi: 10.1007/s11926-015-0495-2. Review.

PMID:
25740704
18.

Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.

Meek IL, Vonkeman HE, van de Laar MA.

BMC Musculoskelet Disord. 2014 May 23;15:174. doi: 10.1186/1471-2474-15-174.

19.

Hyperuricemia and cardiovascular risk.

Grassi D, Desideri G, Di Giacomantonio AV, Di Giosia P, Ferri C.

High Blood Press Cardiovasc Prev. 2014 Dec;21(4):235-42. doi: 10.1007/s40292-014-0046-3. Epub 2014 Feb 20. Review.

PMID:
24554489
20.

Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.

Kok VC, Horng JT, Chang WS, Hong YF, Chang TH.

PLoS One. 2014 Jun 4;9(6):e99102. doi: 10.1371/journal.pone.0099102. eCollection 2014.

Supplemental Content

Support Center